- Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
-
Lee HY, Lee KS, Hwang HS, Lee JW, Ahn MJ, Park K, Kim TS, Yi CA, Chung MJ
- KMID: 1119224
- Korean J Radiol.
- 2010 Dec;11(6):618-626.
- doi: 10.3348/kjr.2010.11.6.618
OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
